郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价In vitro cannabinoid activity profiling of generic ban-evading brominated synthetic cannabinoid receptor agonists and their analogs.

期刊:Drug testing and analysis发表年份:2024作者:Marie H Deventer; Mattias Persson; Caitlyn Norman; Huiling Liu; Matthew J Connolly; Niamh Nic Daéid; Craig McKenzie; Henrik Gréen; Christophe P Stove

药效评价Mechanisms of Allosteric Inhibition of Insulin-Regulated Aminopeptidase.

期刊:Journal of molecular biology发表年份:2024作者:Anastasia Mpakali; Ioanna Barla; Liying Lu; Karthik M Ramesh; Nikolaos Thomaidis; Lawrence J Stern; Petros Giastas; Efstratios Stratikos

药效评价Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel δ Opioid Receptor-Selective Agonist Chemotype.

期刊:The Journal of pharmacology and experimental therapeutics发表年份:2024作者:Yazan J Meqbil; Jhoan Aguilar; Arryn T Blaine; Lan Chen; Robert J Cassell; Amynah A Pradhan; Richard M van Rijn

药效评价Fentanyl-Type Antagonist of the μ-Opioid Receptor: Important Role of Axial Chirality in the Active Conformation.

期刊:Journal of medicinal chemistry发表年份:2024作者:Hironobu Arita; Ryoko Tanaka; Shuntaro Kikukawa; Tsukasa Tomizawa; Haruka Sakata; Masahiko Funada; Kenichi Tomiyama; Masaru Hashimoto; Tomohiko Tasaka; Hidetsugu Tabata; Kayo Nakamura; Kosho Makino; Tetsuta Oshitari; Hideaki Natsugari; Hideyo Takahas